Description

MT-2 10MG

We provide MT-2 as a 10MG synthetic cyclic heptapeptide research compound with a stated 99.1% purity. Furthermore, MT-2 is also known as Melanotan II, an α-MSH analog developed through structural modification and cyclization of a melanocortin peptide framework. Consequently, researchers have investigated MT-2 in relation to melanocortin receptor signaling, melanogenesis, pigmentation biology, energy-homeostasis pathways, and central melanocortin pharmacology. PubChem identifies Melanotan II as a synthetic cyclic heptapeptide with the sequence XDHFRWK and a molecular weight of 1,024.2 g/mol.

MT-2 Key Attributes

• Brand: AvigenLab
• Product Name: MT-2
• Alternative Name: Melanotan II
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Cyclic Heptapeptide
• Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH₂
• Sequence Length: 7 Amino Acids
• Molecular Formula: C₅₀H₆₉N₁₅O₉
• Molecular Weight: 1,024.2 g/mol
• CAS Number: 121062-08-6
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

PubChem records the molecular formula, sequence, molecular weight, and CAS number for the parent Melanotan II structure.

MT-2 Product Overview

We provide MT-2 for research involving melanocortin receptor activity, pigmentation biology, melanogenesis, receptor-ligand interactions, and central melanocortin signaling. Moreover, published research characterizes Melanotan II as a nonselective melanocortin receptor agonist with activity across MC1R, MC3R, MC4R, and MC5R.

Additionally, MC1R plays a central role in melanocyte signaling and pigmentation, while MC3R and MC4R participate in broader metabolic and energy-homeostasis processes. Therefore, MT-2 provides researchers with a defined molecular tool for examining how melanocortin receptor activation produces different biological responses across tissues and receptor subtypes.

Researchers can explore additional research materials through our Online Store.

MT-2 Product Identification

We identify MT-2 through its 10MG quantity, synthetic cyclic heptapeptide structure, stated 99.1% purity, and vial presentation. Accordingly, the product provides straightforward reference points for laboratory inventory and research catalog organization.

Furthermore, PubChem identifies the sequence as XDHFRWK, corresponding to Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH₂. Consequently, researchers can distinguish the material according to its defined sequence, molecular identity, quantity, and physical presentation.

Product Category

We classify MT-2 within our research peptide collection for melanocortin pharmacology, pigmentation research, receptor signaling, and metabolic pathway investigations.

Moreover, research reviews describe Melanotan II as a cyclic α-MSH analog with agonist activity at multiple melanocortin receptor subtypes. Likewise, experimental research has used the compound as a molecular probe for studying melanocortin signaling and its physiological effects.

Scientific Characteristics

The molecular structure of MT-2 contains seven amino acids arranged within a cyclic peptide framework. In particular, structural modification and cyclization distinguish the molecule from linear α-MSH-derived peptides. Furthermore, PubChem reports a molecular formula of C₅₀H₆₉N₁₅O₉ and a molecular weight of 1,024.2 g/mol.

Meanwhile, MC1R signaling connects directly with melanogenesis through intracellular pathways that regulate melanin production. Consequently, MT-2 remains relevant to research examining melanocyte activation, receptor signaling, and pigmentation biology.

Research Applications

We position MT-2 for research involving melanocortin receptor signaling, MC1R activity, melanogenesis, pigmentation biology, MC3R and MC4R signaling, receptor pharmacology, and energy-homeostasis research.

Additionally, published research identifies Melanotan II as an agonist across several melanocortin receptor subtypes. Likewise, experimental studies have used the compound to investigate MC4R-associated effects within neural and metabolic systems.

Nevertheless, receptor activity can produce different downstream responses depending on receptor subtype, tissue distribution, experimental model, and signaling environment. Accordingly, researchers should interpret findings according to the specific experimental system rather than treating all melanocortin pathways as interchangeable.

Product Configuration

We provide MT-2 in a 10MG vial carrying a stated 99.1% purity designation. Furthermore, the defined quantity, molecular identity, purity specification, and vial presentation establish clear reference points for laboratory inventory.

Additionally, the individual-peptide configuration distinguishes this product from other melanocortin-related research materials. Consequently, researchers can organize the product according to its specific molecular identity and physical format.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, synthetic cyclic heptapeptide structure, and clearly defined research-use presentation. Moreover, our product label communicates Not For Human Use | Research Use Only.

Furthermore, the scientific profile encompasses melanocortin receptor pharmacology, melanogenesis, pigmentation research, and central melanocortin signaling. Therefore, the material provides a defined molecular subject for controlled laboratory investigation.

Product Specifications

The molecular identity and chemical specifications correspond with the parent Melanotan II structure recorded by PubChem.

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine melanocortin receptor activation, melanocyte signaling, melanin synthesis, receptor selectivity, and downstream cellular responses. Furthermore, research literature has established MC1R as an important regulator of pigmentation, while MC3R and MC4R contribute to broader physiological signaling.

Nevertheless, researchers should distinguish experimental receptor activity from established clinical outcomes. Published reports have also raised safety concerns surrounding unlicensed use of Melanotan II, including reports involving atypical melanocytic lesions and melanoma.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging displays the 10MG quantity, communicates the stated 99.1% Purity, and identifies the material as Not For Human Use | Research Use Only.

Additionally, the vial format provides straightforward identification within our research catalog. You can explore related materials through our Catalog.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning Melanotan II do not constitute regulatory approval for this specific AvigenLab research presentation.

Moreover, Melanotan II remains an investigational and unapproved compound rather than an approved therapeutic product. Consequently, we focus our documentation on molecular identity, research relevance, product specifications, and published scientific evidence without presenting experimental observations as established therapeutic outcomes.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Furthermore, researchers should maintain appropriate laboratory handling practices and follow product-specific documentation.

Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our collection. The quantity, stated purity, molecular identity, cyclic structure, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Moreover, MT-2 has an established research history within melanocortin pharmacology and pigmentation science. Likewise, researchers have used Melanotan II to investigate melanocortin receptor activity across MC1R, MC3R, MC4R, and MC5R.

Product Reference

Our MT-2 10MG presentation provides a defined synthetic cyclic heptapeptide carrying a stated 99.1% purity designation. We document the material according to its sequence, molecular characteristics, melanocortin research relevance, vial configuration, and Research Use Only classification.

Consequently, the product provides researchers with a clearly identified material for investigating melanocortin receptor signaling, MC1R-mediated melanogenesis, pigmentation biology, MC3R and MC4R pathways, and related receptor mechanisms. Furthermore, the established research literature surrounding Melanotan II provides a substantial scientific foundation for continued investigation into melanocortin receptor pharmacology.

For additional product information, researchers can also visit our Shop.